If the future of psychotherapy lies in psychopharmaceuticals and the short-term therapies stipulated by HMOs, argues Yalom, then the profession is in trouble. Yalom, the recipient of both major awards ...
I'm fortunate to have spoken with Irvin Yalom a few times. The interviews usually have a particular focus, but as it is in many conversations, some of the best material is off topic. Today I thought I ...